These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37661653)

  • 1. Improvement of objective ocular redness measured with Keratograph 5M in glaucoma patients after instilling brimonidine drops.
    Montolío-Marzo E; Fernández-Narros R; Morales-Fernández L; García-Bella J; Sáenz-Francés F; García-Feijoo J; Martínez-de-la-Casa JM
    Eur J Ophthalmol; 2024 Mar; 34(2):480-486. PubMed ID: 37661653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular Redness Measured with the Keratograph 5M in Patients Using Anti-Glaucoma Eye Drops.
    Pérez Bartolomé F; Martínez de la Casa JM; Arriola Villalobos P; Fernández Pérez C; Polo V; Sánchez Jean R; García Feijoó J
    Semin Ophthalmol; 2018; 33(5):643-650. PubMed ID: 29144869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Objective ocular surface tolerance in patients with glaucoma treated with topical preserved or unpreserved prostaglandin analogues.
    El Ameen A; Vandermeer G; Khanna RK; Pisella PJ
    Eur J Ophthalmol; 2019 Nov; 29(6):645-653. PubMed ID: 30301370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparisons of efficacy and safety between preserved and preservative-free brimonidine tartrate in glaucoma and ocular hypertension: a parallel-grouped, randomized trial.
    Kim KE; Lee CK; Shin J; Kim Y; Rho S
    Sci Rep; 2023 Apr; 13(1):5700. PubMed ID: 37029145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular Surface Disease in Patients under Topical Treatment for Glaucoma.
    Pérez-Bartolomé F; Martínez-de-la-Casa JM; Arriola-Villalobos P; Fernández-Pérez C; Polo V; García-Feijoó J
    Eur J Ophthalmol; 2017 Nov; 27(6):694-704. PubMed ID: 28497458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservative-free
    Duru Z; Ozsaygili C
    Cutan Ocul Toxicol; 2020 Mar; 39(1):21-24. PubMed ID: 31615279
    [No Abstract]   [Full Text] [Related]  

  • 7. Crossover Randomized Study of Pharmacologic Effects of Ripasudil-Brimonidine Fixed-Dose Combination Versus Ripasudil or Brimonidine.
    Tanihara H; Yamamoto T; Aihara M; Koizumi N; Minami H; Kojima S; Isobe T; Kanazawa M; Suganami H;
    Adv Ther; 2023 Aug; 40(8):3559-3573. PubMed ID: 37330927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraocular light scatter in patients on topical intraocular pressure-lowering medication.
    Pérez-Bartolomé F; Martínez de la Casa JM; Arriola-Villalobos P; Fernández-Pérez C; García-Feijoó J
    Eur J Ophthalmol; 2018 Nov; 28(6):652-661. PubMed ID: 29631441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular Surface Disease in Glaucoma Patients Randomized to Benzalkonium Chloride-Containing Latanoprost and Preservative-Free Bimatoprost.
    Wu JH; Wang TH; Huang JY; Su CC
    J Ocul Pharmacol Ther; 2021 Dec; 37(10):556-564. PubMed ID: 34610257
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of ocular redness measurements obtained with keratograph 5M and correlation with subjective grading scales.
    Pérez-Bartolomé F; Sanz-Pozo C; Martínez-de la Casa JM; Arriola-Villalobos P; Fernández-Pérez C; García-Feijoó J
    J Fr Ophtalmol; 2018 Nov; 41(9):836-846. PubMed ID: 30293826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Ocular Surface Disease in Patients With Glaucoma: Clinical Parameters, Self-report Assessment, and Keratograph Analysis.
    Portela RC; Fares NT; Machado LF; São Leão AF; de Freitas D; Paranhos A; Prata TS; Gracitelli CPB
    J Glaucoma; 2018 Sep; 27(9):794-801. PubMed ID: 29916999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of steroid eyedrops after trabeculectomy in glaucoma patients: a keratograph analysis.
    Fares NT; Portela RC; Machado LF; Polizelli M; Freitas D; Paranhos A; Prata TS; Gracitelli CPB
    Arq Bras Oftalmol; 2021; 84(4):345-351. PubMed ID: 33567039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of ocular redness score evaluated automatically in glaucoma patients under different topical medications.
    Giannaccare G; Pellegrini M; Bernabei F; Senni C; Aloi M; Scalzo GC; Ceravolo D; Iovino C; Scorcia V
    Eur J Ophthalmol; 2021 Sep; 31(5):2405-2411. PubMed ID: 33148017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brimonidine tartrate ophthalmic solution 0.025% for redness relief: an overview of safety and efficacy.
    Lee JS; Kim CY
    Expert Rev Clin Pharmacol; 2022 Aug; 15(8):911-919. PubMed ID: 35951740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis.
    Harasymowycz P; Hutnik C; Rouland JF; Negrete FJM; Economou MA; Denis P; Baudouin C
    Adv Ther; 2021 Jun; 38(6):3019-3031. PubMed ID: 33891269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ocular Surface Evaluation in Patients Treated with Prostaglandin Analogues Considering Preservative Agent].
    Mlčáková E; Mlčák P; Karhanová M; Langová K; Marešová K
    Cesk Slov Oftalmol; 2016; 72(4):120-127. PubMed ID: 27860477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study.
    Inatani M; Orii Y; Iwasaki K; Arimura S; Sunagawa H; Shiokawa M; Inoue K; Sakono T; Sakono T; Kuwamura R; Yoshida A; Oi J; Kuwayama Y; Kano K; Kido N; Matsuyama A; Ozaki M; Abe H; Inoue C; Nakagawa S; Musashi K; Kanamori A; Lee J; Otani S; Aoki R; Tanabe H; Nakakura S; Suzuki K; Sagara T; Saito Y; Sameshima M; Urahashi M; Watanabe-Kitamura F; Inoue T; Kagaya F; Murai Y; Mori S; Ueda K; Kurimoto T; Yamada-Nakanishi Y; Nakamura M; Yamashita T; Ishiyama S; Manabe S; Takaki K; Hayashi K; Ishida A; Tsutsui A; Manabe K; Tanito M
    Adv Ther; 2023 Sep; 40(9):4074-4092. PubMed ID: 37452961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brimonidine Ophthalmic Solution 0.025% for Reduction of Ocular Redness: A Randomized Clinical Trial.
    McLaurin E; Cavet ME; Gomes PJ; Ciolino JB
    Optom Vis Sci; 2018 Mar; 95(3):264-271. PubMed ID: 29461408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of ocular surface disease in glaucoma patients with benzalkonium chloride-preserved latanoprost eye drops: a short-term longitudinal study.
    Su CC; Lee YC; Lee PRC
    Graefes Arch Clin Exp Ophthalmol; 2021 May; 259(5):1243-1251. PubMed ID: 33433642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brimonidine and brinzolamide for treating glaucoma and ocular hypertension; a safety evaluation.
    Lusthaus JA; Goldberg I
    Expert Opin Drug Saf; 2017 Sep; 16(9):1071-1078. PubMed ID: 28656780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.